Home/Filings/4/0001214659-21-006408
4//SEC Filing

Jordan Edward P. 4

Accession 0001214659-21-006408

CIK 0001293310other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 5:10 PM ET

Size

9.3 KB

Accession

0001214659-21-006408

Insider Transaction Report

Form 4
Period: 2021-06-08
Edward P. Jordan
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-06-08$9.65/sh+14,700$141,85514,700 total
  • Sale

    Common Stock

    2021-06-08$20.08/sh14,700$295,1760 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-06-0814,70073,500 total
    Exercise: $9.65From: 2020-12-31Exp: 2030-09-18Common Stock (14,700 underlying)
Footnotes (2)
  • [F1]On September 18, 2020, Mr. Jordan was granted an option to purchase 88,200 shares of the Company's common stock, which vests in 12 ratable quarterly installments commencing December 31, 2020.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.21, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).

Issuer

HUMANIGEN, INC

CIK 0001293310

Entity typeother

Related Parties

1
  • filerCIK 0001600814

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:10 PM ET
Size
9.3 KB